Are there potential treatments beyond dietary management for galactosemia?
Currently, the primary treatment for galactosemia involves dietary management, but research is ongoing to explore additional therapeutic options. Gene therapy offers a potential future treatment by correcting the defective GALT gene. Enzyme replacement therapy is another area of research, aiming to supplement the deficient enzyme in affected individuals. These approaches could provide more comprehensive management of the toxicological effects associated with GALT gene mutations.
